IRX5iroquois homeobox 5
Autism Reports / Total Reports
2 / 3Rare Variants / Common Variants
3 / 0Aliases
-Associated Syndromes
16q12.1-q21 deletion syndromeChromosome Band
16q12.2Associated Disorders
-Relevance to Autism
Whole genome and/or whole exome sequencing of 435 individuals in 116 ASD families in Viggiano et al., 2024 identified a de novo nonsense variant in the IRX5 gene in a male ASD proband who also presented with atypical language and borderline IQ. A de novo frameshift variant and a de novo in-frame deletion variant in this gene has previously been reported in a female SPARK proband and a male MSSNG proband, respectively, in Zhou et al., 2022. Apuzzo et al., 2020 reported that IRX5 was located with the minimal region of overlap in 16q12.1-q21 deletion syndrome, an extremely rare microdeletion syndrome characterized by dysmorphic features, short stature, microcephaly, eye abnormalities, epilepsy, development delay, intellectual disability, and autism spectrum disorder.
Molecular Function
This gene encodes a member of the iroquois homeobox gene family, which are involved in several embryonic developmental processes. Knockout mice lacking this gene show that it is required for retinal cone bipolar cell differentiation, and that it negatively regulates potassium channel gene expression in the heart to ensure coordinated cardiac repolarization. Hamamy syndrome (OMIM 611174) is an autosomal recessive disorder characterized by severe hypertelorism with midface prominence, myopia, intellectual disability, and bone fragility caused by homozygous mutations in the IRX5 gene, while cone dystrophy with early-onset tritanopic color vision defect (OMIM 619649) is a contiguous gene duplication syndrome on chromosome 16q12 involving the IRX5 gene.
External Links
SFARI Genomic Platforms
Reports related to IRX5 (3 Reports)
# | Type | Title | Author, Year | Autism Report | Associated Disorders |
---|---|---|---|---|---|
1 | Support | - | Diletta Apuzzo et al. (2020) | No | - |
2 | Support | - | Zhou X et al. (2022) | Yes | - |
3 | Primary | - | Marta Viggiano et al. (2024) | Yes | ID |
Rare Variants (3)
Status | Allele Change | Residue Change | Variant Type | Inheritance Pattern | Parental Transmission | Family Type | PubMed ID | Author, Year |
---|---|---|---|---|---|---|---|---|
c.28C>T | p.Gln10Ter | stop_gained | De novo | - | Simplex | 38519481 | Marta Viggiano et al. (2024) | |
c.232_234del | p.Ala78del | inframe_deletion | De novo | - | Simplex | 35982159 | Zhou X et al. (2022) | |
c.1010dup | p.Leu337PhefsTer119 | frameshift_variant | De novo | - | - | 35982159 | Zhou X et al. (2022) |
Common Variants
No common variants reported.
SFARI Gene score
Suggestive Evidence, Syndromic


Score Delta: Score remained at 3S
criteria met
See SFARI Gene'scoring criteriaThe literature is replete with relatively small studies of candidate genes, using either common or rare variant approaches, which do not reach the criteria set out for categories 1 and 2. Genes that had two such lines of supporting evidence were placed in category 3, and those with one line of evidence were placed in category 4. Some additional lines of "accessory evidence" (indicated as "acc" in the score cards) could also boost a gene from category 4 to 3.
The syndromic category includes mutations that are associated with a substantial degree of increased risk and consistently linked to additional characteristics not required for an ASD diagnosis. If there is independent evidence implicating a gene in idiopathic ASD, it will be listed as "#S" (e.g., 2S, 3S, etc.). If there is no such independent evidence, the gene will be listed simply as "S."
7/1/2024

Increased from to 3S
Krishnan Probability Score
Score 0.49184523481413
Ranking 5001/25841 scored genes
[Show Scoring Methodology]
Sanders TADA Score
Score 0.93778739618531
Ranking 13642/18665 scored genes
[Show Scoring Methodology]
Zhang D Score
Score -0.58788464177296
Ranking 19829/20870 scored genes
[Show Scoring Methodology]